心肌损伤标志物的研究进展  

Research Progress of Markers of Myocardial Injury

作　　者：李盘[1] 周静[1] 高峰[1] 

机构地区：[1]延安大学附属医院心内科三病区,陕西延安716000

出　　处：《医学综述》2014年第10期1747-1750,共4页Medical Recapitulate

摘　　要：急性冠状动脉综合征是动脉硬化导致器官病变的最常见类型,也是严重危害人类健康的常见病,心肌梗死的病死率极高。随着心脏介入技术及溶栓技术不断完善,早期急性冠状动脉综合征诊断变得至关重要。血液生化标志物具有高度的敏感性和特异性,目前已有越来越多的血液生化标志物在临床中得到应用。该文就对心肌损伤标志物研究领域的进展进行综述。Acute coronary syndrome is the most common type of arteriosclerosis leading to organ damage,and also a serious hazard to human health of common diseases,and the high mortality of myocardial infarction is extremely high.With the continuous improvement of interventional cardiology technology and thrombolytic technology,the diagnosis of early acute coronary syndrome becomes critical.Biochemical markers of the blood have a high degree of sensitivity and specificity,and more and more blood biochemical markers are applied in clinical.Here is to make a review of the progress in the field of markers of myocardial injury.

关 键 词：急性冠状动脉综合征 生化标志物 诊断 预后 

分 类 号：R541.4[医药卫生—心血管疾病]